

<!--XBRL document created by RR Donnelley Tagger version 10.0.0.187; Copyright (C) RR Donnelley-->
<!--Based on XBRL 2.1-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="mnov-20120930.xsd#DocumentAndEntityInformation" roleURI="http://www.medicinova.com/role/DocumentAndEntityInformation" />
  <roleRef xlink:type="simple" xlink:href="mnov-20120930.xsd#BalanceSheets" roleURI="http://www.medicinova.com/role/BalanceSheets" />
  <roleRef xlink:type="simple" xlink:href="mnov-20120930.xsd#BalanceSheetsParenthetical" roleURI="http://www.medicinova.com/role/BalanceSheetsParenthetical" />
  <roleRef xlink:type="simple" xlink:href="mnov-20120930.xsd#StatementsOfOperations" roleURI="http://www.medicinova.com/role/StatementsOfOperations" />
  <roleRef xlink:type="simple" xlink:href="mnov-20120930.xsd#StatementsOfCashFlows" roleURI="http://www.medicinova.com/role/StatementsOfCashFlows" />
  <roleRef xlink:type="simple" xlink:href="mnov-20120930.xsd#InterimFinancialInformation" roleURI="http://www.medicinova.com/role/InterimFinancialInformation" />
  <roleRef xlink:type="simple" xlink:href="mnov-20120930.xsd#AvigenTransaction" roleURI="http://www.medicinova.com/role/AvigenTransaction" />
  <roleRef xlink:type="simple" xlink:href="mnov-20120930.xsd#FairValueMeasurements" roleURI="http://www.medicinova.com/role/FairValueMeasurements" />
  <roleRef xlink:type="simple" xlink:href="mnov-20120930.xsd#Debt" roleURI="http://www.medicinova.com/role/Debt" />
  <roleRef xlink:type="simple" xlink:href="mnov-20120930.xsd#NetLossPerShare" roleURI="http://www.medicinova.com/role/NetLossPerShare" />
  <roleRef xlink:type="simple" xlink:href="mnov-20120930.xsd#ComprehensiveIncomeLoss" roleURI="http://www.medicinova.com/role/ComprehensiveIncomeLoss" />
  <roleRef xlink:type="simple" xlink:href="mnov-20120930.xsd#BalanceSheetDetail" roleURI="http://www.medicinova.com/role/BalanceSheetDetail" />
  <roleRef xlink:type="simple" xlink:href="mnov-20120930.xsd#ShareBasedPayments" roleURI="http://www.medicinova.com/role/ShareBasedPayments" />
  <roleRef xlink:type="simple" xlink:href="mnov-20120930.xsd#IncomeTaxes" roleURI="http://www.medicinova.com/role/IncomeTaxes" />
  <roleRef xlink:type="simple" xlink:href="mnov-20120930.xsd#CommitmentsAndContingencies" roleURI="http://www.medicinova.com/role/CommitmentsAndContingencies" />
  <roleRef xlink:type="simple" xlink:href="mnov-20120930.xsd#StockholdersEquity" roleURI="http://www.medicinova.com/role/StockholdersEquity" />
  <roleRef xlink:type="simple" xlink:href="mnov-20120930.xsd#InterimFinancialInformationPolicies" roleURI="http://www.medicinova.com/role/InterimFinancialInformationPolicies" />
  <roleRef xlink:type="simple" xlink:href="mnov-20120930.xsd#FairValueMeasurementsTables" roleURI="http://www.medicinova.com/role/FairValueMeasurementsTables" />
  <roleRef xlink:type="simple" xlink:href="mnov-20120930.xsd#ComprehensiveIncomeLossTables" roleURI="http://www.medicinova.com/role/ComprehensiveIncomeLossTables" />
  <roleRef xlink:type="simple" xlink:href="mnov-20120930.xsd#BalanceSheetDetailTables" roleURI="http://www.medicinova.com/role/BalanceSheetDetailTables" />
  <roleRef xlink:type="simple" xlink:href="mnov-20120930.xsd#ShareBasedPaymentsTables" roleURI="http://www.medicinova.com/role/ShareBasedPaymentsTables" />
  <roleRef xlink:type="simple" xlink:href="mnov-20120930.xsd#StockholdersEquityTables" roleURI="http://www.medicinova.com/role/StockholdersEquityTables" />
  <roleRef xlink:type="simple" xlink:href="mnov-20120930.xsd#AvigenTransactionDetailsTexual" roleURI="http://www.medicinova.com/role/AvigenTransactionDetailsTexual" />
  <roleRef xlink:type="simple" xlink:href="mnov-20120930.xsd#FairValueMeasurementsDetails" roleURI="http://www.medicinova.com/role/FairValueMeasurementsDetails" />
  <roleRef xlink:type="simple" xlink:href="mnov-20120930.xsd#DebtDetails" roleURI="http://www.medicinova.com/role/DebtDetails" />
  <roleRef xlink:type="simple" xlink:href="mnov-20120930.xsd#NetLossPerShareDetails" roleURI="http://www.medicinova.com/role/NetLossPerShareDetails" />
  <roleRef xlink:type="simple" xlink:href="mnov-20120930.xsd#ComprehensiveIncomeLossDetails" roleURI="http://www.medicinova.com/role/ComprehensiveIncomeLossDetails" />
  <roleRef xlink:type="simple" xlink:href="mnov-20120930.xsd#BalanceSheetDetailDetails" roleURI="http://www.medicinova.com/role/BalanceSheetDetailDetails" />
  <roleRef xlink:type="simple" xlink:href="mnov-20120930.xsd#ShareBasedPaymentsDetails" roleURI="http://www.medicinova.com/role/ShareBasedPaymentsDetails" />
  <roleRef xlink:type="simple" xlink:href="mnov-20120930.xsd#StockholdersEquityDetails" roleURI="http://www.medicinova.com/role/StockholdersEquityDetails" />
  <roleRef xlink:type="simple" xlink:href="mnov-20120930.xsd#StockholdersEquityDetailsTextual" roleURI="http://www.medicinova.com/role/StockholdersEquityDetailsTextual" />
  <roleRef xlink:type="simple" xlink:href="mnov-20120930.xsd#InterimFinancialInformationDetails" roleURI="http://www.medicinova.com/role/InterimFinancialInformationDetails" />
  <roleRef xlink:type="simple" xlink:href="mnov-20120930.xsd#IncomeTaxesDetails" roleURI="http://www.medicinova.com/role/IncomeTaxesDetails" />
  <roleRef xlink:type="simple" xlink:href="mnov-20120930.xsd#ShareBasedPaymentsDetailsTextual" roleURI="http://www.medicinova.com/role/ShareBasedPaymentsDetailsTextual" />
  <roleRef xlink:type="simple" xlink:href="mnov-20120930.xsd#JointVenture" roleURI="http://www.medicinova.com/role/JointVenture" />
  <roleRef xlink:type="simple" xlink:href="mnov-20120930.xsd#JointVentureDetails" roleURI="http://www.medicinova.com/role/JointVentureDetails" />
  <roleRef xlink:type="simple" xlink:href="mnov-20120930.xsd#NetLossPerShareTables" roleURI="http://www.medicinova.com/role/NetLossPerShareTables" />
  <roleRef xlink:type="simple" xlink:href="mnov-20120930.xsd#NetLossPerShareDetailsTextual" roleURI="http://www.medicinova.com/role/NetLossPerShareDetailsTextual" />
  <calculationLink xlink:type="extended" xlink:role="http://www.medicinova.com/role/DocumentAndEntityInformation" xlink:title="00 - Document - Document and Entity Information" />
  <calculationLink xlink:type="extended" xlink:role="http://www.medicinova.com/role/BalanceSheets" xlink:title="0110 - Statement - Consolidated Balance Sheets">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_634566178989439455" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_634566178989439455" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity_634566178989439455" xlink:to="us-gaap_StockholdersEquity_634566178989439455" order="40" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_634566178989439455" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity_634566178989439455" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_634566178989439455" order="120" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="us-gaap_TreasuryStockValue_634566178989429454" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity_634566178989439455" xlink:to="us-gaap_TreasuryStockValue_634566178989429454" order="100" use="optional" weight="-1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_634566178989429454" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity_634566178989439455" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_634566178989429454" order="80" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital_634566178989429454" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity_634566178989439455" xlink:to="us-gaap_AdditionalPaidInCapital_634566178989429454" order="60" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue_634566178989429454" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity_634566178989439455" xlink:to="us-gaap_CommonStockValue_634566178989429454" order="40" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue_634566178989429454" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity_634566178989439455" xlink:to="us-gaap_PreferredStockValue_634566178989429454" order="20" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities_634566178989429454" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity_634566178989439455" xlink:to="us-gaap_Liabilities_634566178989429454" order="20" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="us-gaap_DeferredTaxLiabilitiesNoncurrent_634566178989419453" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities_634566178989429454" xlink:to="us-gaap_DeferredTaxLiabilitiesNoncurrent_634566178989419453" order="40" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent_634566178989419453" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities_634566178989429454" xlink:to="us-gaap_LiabilitiesCurrent_634566178989419453" order="20" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_634566178989419453" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent_634566178989419453" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_634566178989419453" order="80" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent_634566178989419453" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent_634566178989419453" xlink:to="us-gaap_AccruedLiabilitiesCurrent_634566178989419453" order="60" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent_634566178989409452" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent_634566178989419453" xlink:to="us-gaap_AccountsPayableCurrent_634566178989409452" order="20" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets_634566178989409452" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_634566178989409452" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets_634566178989409452" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_634566178989409452" order="100" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:label="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_634566178989409452" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets_634566178989409452" xlink:to="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_634566178989409452" order="80" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="mnov-20120930.xsd#mnov_InProcessResearchAndDevelopment" xlink:label="mnov_InProcessResearchAndDevelopment_634566178989409452" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets_634566178989409452" xlink:to="mnov_InProcessResearchAndDevelopment_634566178989409452" order="60" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill_634566178989409452" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets_634566178989409452" xlink:to="us-gaap_Goodwill_634566178989409452" order="40" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent_634566178989409452" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets_634566178989409452" xlink:to="us-gaap_AssetsCurrent_634566178989409452" order="20" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_634566178989409452" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent_634566178989409452" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_634566178989409452" order="40" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_634566178989399451" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent_634566178989409452" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_634566178989399451" order="20" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_DeferredRevenueCurrent" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent_634566178989419453" xlink:to="loc_DeferredRevenueCurrent" order="40" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="loc_DeferredRevenueNoncurrent" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities_634566178989429454" xlink:to="loc_DeferredRevenueNoncurrent" order="60" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.medicinova.com/role/BalanceSheetsParenthetical" xlink:title="0111 - Statement - Consolidated Balance Sheets (Parenthetical)" />
  <calculationLink xlink:type="extended" xlink:role="http://www.medicinova.com/role/StatementsOfOperations" xlink:title="0120 - Statement - Consolidated Statements of Operations and Comprehensive Loss (Unaudited)">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" order="40" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_634566178989469458" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_634566178989469458" order="20" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="mnov-20120930.xsd#mnov_DeemedDividendResultingFromConvertiblePreferredStock" xlink:label="mnov_DeemedDividendResultingFromConvertiblePreferredStock_634566178989469458" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_634566178989469458" xlink:to="mnov_DeemedDividendResultingFromConvertiblePreferredStock_634566178989469458" order="60" use="optional" weight="-1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockAccretionOfRedemptionDiscount" xlink:label="us-gaap_PreferredStockAccretionOfRedemptionDiscount_634566178989469458" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_634566178989469458" xlink:to="us-gaap_PreferredStockAccretionOfRedemptionDiscount_634566178989469458" order="40" use="optional" weight="-1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_634566178989469458" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_634566178989469458" xlink:to="us-gaap_NetIncomeLoss_634566178989469458" order="20" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit_634566178989469458" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss_634566178989469458" xlink:to="us-gaap_IncomeTaxExpenseBenefit_634566178989469458" order="40" use="optional" weight="-1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss_634566178989469458" xlink:to="loc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="20" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherNonoperatingIncome" xlink:label="us-gaap_OtherNonoperatingIncome_634566178989469458" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_OtherNonoperatingIncome_634566178989469458" order="100" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense_634566178989469458" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_InterestExpense_634566178989469458" order="80" use="optional" weight="-1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherNonoperatingExpense" xlink:label="us-gaap_OtherNonoperatingExpense_634566178989459457" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_OtherNonoperatingExpense_634566178989459457" order="60" use="optional" weight="-1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="us-gaap_UnrealizedGainLossOnInvestments_634566178989459457" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_UnrealizedGainLossOnInvestments_634566178989459457" order="40" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss_634566178989459457" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_OperatingIncomeLoss_634566178989459457" order="20" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses_634566178989459457" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss_634566178989459457" xlink:to="us-gaap_OperatingExpenses_634566178989459457" order="40" use="optional" weight="-1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense_634566178989459457" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses_634566178989459457" xlink:to="us-gaap_GeneralAndAdministrativeExpense_634566178989459457" order="60" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense_634566178989459457" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses_634566178989459457" xlink:to="us-gaap_ResearchAndDevelopmentExpense_634566178989459457" order="40" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue_634566178989459457" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses_634566178989459457" xlink:to="us-gaap_CostOfRevenue_634566178989459457" order="20" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues_634566178989459457" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss_634566178989459457" xlink:to="us-gaap_Revenues_634566178989459457" order="20" use="optional" weight="1" priority="1" />
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.medicinova.com/role/StatementsOfCashFlows" xlink:title="0130 - Statement - Consolidated Statements of Cash Flows (Unaudited)">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_634566178989509462" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_634566178989509462" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_634566178989509462" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_634566178989509462" order="60" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock_634566178989509462" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_634566178989509462" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock_634566178989509462" order="160" use="optional" weight="-1" priority="1" />
    <loc xlink:type="locator" xlink:href="mnov-20120930.xsd#mnov_ProceedsFromConversionOfConvertibleNotes" xlink:label="mnov_ProceedsFromConversionOfConvertibleNotes_634566178989509462" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_634566178989509462" xlink:to="mnov_ProceedsFromConversionOfConvertibleNotes_634566178989509462" order="140" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:label="us-gaap_RepaymentsOfDebt_634566178989509462" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_634566178989509462" xlink:to="us-gaap_RepaymentsOfDebt_634566178989509462" order="120" use="optional" weight="-1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt_634566178989499461" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_634566178989509462" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt_634566178989499461" order="100" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="mnov-20120930.xsd#mnov_RepaymentsOfArsLoan" xlink:label="mnov_RepaymentsOfArsLoan_634566178989499461" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_634566178989509462" xlink:to="mnov_RepaymentsOfArsLoan_634566178989499461" order="80" use="optional" weight="-1" priority="1" />
    <loc xlink:type="locator" xlink:href="mnov-20120930.xsd#mnov_ProceedsFromArsLoan" xlink:label="mnov_ProceedsFromArsLoan_634566178989499461" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_634566178989509462" xlink:to="mnov_ProceedsFromArsLoan_634566178989499461" order="60" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_634566178989499461" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_634566178989509462" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_634566178989499461" order="40" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_634566178989499461" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_634566178989509462" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_634566178989499461" order="20" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_634566178989499461" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_634566178989509462" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_634566178989499461" order="40" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_634566178989489460" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities_634566178989499461" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_634566178989489460" order="120" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_634566178989489460" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities_634566178989499461" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_634566178989489460" order="100" use="optional" weight="-1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_634566178989489460" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities_634566178989499461" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_634566178989489460" order="80" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="us-gaap_PaymentsToAcquireInvestments_634566178989489460" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities_634566178989499461" xlink:to="us-gaap_PaymentsToAcquireInvestments_634566178989489460" order="60" use="optional" weight="-1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_634566178989489460" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities_634566178989499461" xlink:to="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_634566178989489460" order="40" use="optional" weight="-1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_634566178989489460" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_634566178989509462" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_634566178989489460" order="20" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseOfRestrictedInvestments" xlink:label="us-gaap_IncreaseDecreaseOfRestrictedInvestments_634566178989489460" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_634566178989489460" xlink:to="us-gaap_IncreaseDecreaseOfRestrictedInvestments_634566178989489460" order="240" use="optional" weight="-1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_634566178989489460" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_634566178989489460" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_634566178989489460" order="220" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="mnov-20120930.xsd#mnov_IncreaseDecreaseInAccountsPayableAccruedExpensesIncomeTaxesPayableAndDeferredRent" xlink:label="mnov_IncreaseDecreaseInAccountsPayableAccruedExpensesIncomeTaxesPayableAndDeferredRent_634566178989489460" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_634566178989489460" xlink:to="mnov_IncreaseDecreaseInAccountsPayableAccruedExpensesIncomeTaxesPayableAndDeferredRent_634566178989489460" order="200" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_634566178989479459" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_634566178989489460" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_634566178989479459" order="180" use="optional" weight="-1" priority="1" />
    <loc xlink:type="locator" xlink:href="mnov-20120930.xsd#mnov_ImpairmentOfSublease" xlink:label="mnov_ImpairmentOfSublease_634566178989479459" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_634566178989489460" xlink:to="mnov_ImpairmentOfSublease_634566178989479459" order="160" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:label="us-gaap_GainLossOnDispositionOfAssets_634566178989479459" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_634566178989489460" xlink:to="us-gaap_GainLossOnDispositionOfAssets_634566178989479459" order="140" use="optional" weight="-1" priority="1" />
    <loc xlink:type="locator" xlink:href="mnov-20120930.xsd#mnov_ImpairmentChargeGainNetOnInvestmentSecuritiesAndArsPut" xlink:label="mnov_ImpairmentChargeGainNetOnInvestmentSecuritiesAndArsPut_634566178989479459" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_634566178989489460" xlink:to="mnov_ImpairmentChargeGainNetOnInvestmentSecuritiesAndArsPut_634566178989479459" order="120" use="optional" weight="-1" priority="1" />
    <loc xlink:type="locator" xlink:href="mnov-20120930.xsd#mnov_AmortizationOfPremiumDiscountOnInvestmentSecuritiesConvertibleNotesAndDebtDiscountAndIssuanceCosts" xlink:label="mnov_AmortizationOfPremiumDiscountOnInvestmentSecuritiesConvertibleNotesAndDebtDiscountAndIssuanceCosts_634566178989479459" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_634566178989489460" xlink:to="mnov_AmortizationOfPremiumDiscountOnInvestmentSecuritiesConvertibleNotesAndDebtDiscountAndIssuanceCosts_634566178989479459" order="100" use="optional" weight="-1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization_634566178989479459" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_634566178989489460" xlink:to="us-gaap_DepreciationDepletionAndAmortization_634566178989479459" order="80" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation_634566178989479459" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_634566178989489460" xlink:to="us-gaap_ShareBasedCompensation_634566178989479459" order="60" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_634566178989479459" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_634566178989489460" xlink:to="us-gaap_NetIncomeLoss_634566178989479459" order="40" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RecognitionOfDeferredRevenue" xlink:label="loc_RecognitionOfDeferredRevenue" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_634566178989489460" xlink:to="loc_RecognitionOfDeferredRevenue" order="20" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:label="loc_PaymentsToAcquireInterestInJointVenture" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities_634566178989499461" xlink:to="loc_PaymentsToAcquireInterestInJointVenture" order="20" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="mnov-20120930.xsd#mnov_NonCashWarrantAmortization" xlink:label="mnov_NonCashWarrantAmortization" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_634566178989489460" xlink:to="mnov_NonCashWarrantAmortization" order="50" use="optional" weight="1" priority="1" />
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.medicinova.com/role/InterimFinancialInformation" xlink:title="0201 - Disclosure - Interim Financial Information" />
  <calculationLink xlink:type="extended" xlink:role="http://www.medicinova.com/role/AvigenTransaction" xlink:title="0202 - Disclosure - Avigen Transaction" />
  <calculationLink xlink:type="extended" xlink:role="http://www.medicinova.com/role/FairValueMeasurements" xlink:title="0204 - Disclosure - Fair Value Measurements" />
  <calculationLink xlink:type="extended" xlink:role="http://www.medicinova.com/role/Debt" xlink:title="0205 - Disclosure - Long-term Debt" />
  <calculationLink xlink:type="extended" xlink:role="http://www.medicinova.com/role/NetLossPerShare" xlink:title="0206 - Disclosure - Net Loss Per Share" />
  <calculationLink xlink:type="extended" xlink:role="http://www.medicinova.com/role/ComprehensiveIncomeLoss" xlink:title="0207 - Disclosure - Accumulated Other Comprehensive Loss" />
  <calculationLink xlink:type="extended" xlink:role="http://www.medicinova.com/role/BalanceSheetDetail" xlink:title="0208 - Disclosure - Balance Sheet Details" />
  <calculationLink xlink:type="extended" xlink:role="http://www.medicinova.com/role/ShareBasedPayments" xlink:title="0209 - Disclosure - Stock-Based Compensation" />
  <calculationLink xlink:type="extended" xlink:role="http://www.medicinova.com/role/IncomeTaxes" xlink:title="0210 - Disclosure - Income Taxes" />
  <calculationLink xlink:type="extended" xlink:role="http://www.medicinova.com/role/CommitmentsAndContingencies" xlink:title="0211 - Disclosure - Commitments and Contingencies" />
  <calculationLink xlink:type="extended" xlink:role="http://www.medicinova.com/role/StockholdersEquity" xlink:title="0212 - Disclosure - Stockholders' Equity" />
  <calculationLink xlink:type="extended" xlink:role="http://www.medicinova.com/role/InterimFinancialInformationPolicies" xlink:title="0401 - Disclosure - Interim Financial Information (Policies)" />
  <calculationLink xlink:type="extended" xlink:role="http://www.medicinova.com/role/ComprehensiveIncomeLossTables" xlink:title="0507 - Disclosure - Accumulated Other Comprehensive Loss (Tables)" />
  <calculationLink xlink:type="extended" xlink:role="http://www.medicinova.com/role/BalanceSheetDetailTables" xlink:title="0508 - Disclosure - Balance Sheet Details (Tables)" />
  <calculationLink xlink:type="extended" xlink:role="http://www.medicinova.com/role/ShareBasedPaymentsTables" xlink:title="0509 - Disclosure - Stock-Based Compensation (Tables)" />
  <calculationLink xlink:type="extended" xlink:role="http://www.medicinova.com/role/StockholdersEquityTables" xlink:title="0512 - Disclosure - Stockholders' Equity (Tables)" />
  <calculationLink xlink:type="extended" xlink:role="http://www.medicinova.com/role/AvigenTransactionDetailsTexual" xlink:title="0602 - Disclosure - Avigen Transaction (Details)" />
  <calculationLink xlink:type="extended" xlink:role="http://www.medicinova.com/role/FairValueMeasurementsDetails" xlink:title="0604 - Disclosure - Fair Value Measurements (Details)" />
  <calculationLink xlink:type="extended" xlink:role="http://www.medicinova.com/role/DebtDetails" xlink:title="0605 - Disclosure - Long-term Debt (Details)" />
  <calculationLink xlink:type="extended" xlink:role="http://www.medicinova.com/role/NetLossPerShareDetails" xlink:title="0606 - Disclosure - Net Loss Per Share (Details)" />
  <calculationLink xlink:type="extended" xlink:role="http://www.medicinova.com/role/ComprehensiveIncomeLossDetails" xlink:title="0607 - Disclosure - Accumulated Other Comprehensive Loss (Details)" />
  <calculationLink xlink:type="extended" xlink:role="http://www.medicinova.com/role/BalanceSheetDetailDetails" xlink:title="0608 - Disclosure - Balance Sheet Detail (Details)" />
  <calculationLink xlink:type="extended" xlink:role="http://www.medicinova.com/role/ShareBasedPaymentsDetails" xlink:title="0609 - Disclosure - Stock-Based Compensation (Details)" />
  <calculationLink xlink:type="extended" xlink:role="http://www.medicinova.com/role/StockholdersEquityDetails" xlink:title="0612 - Disclosure - Stockholders' Equity (Details)" />
  <calculationLink xlink:type="extended" xlink:role="http://www.medicinova.com/role/StockholdersEquityDetailsTextual" xlink:title="06121 - Disclosure - Stockholders' Equity (Details Textual)" />
  <calculationLink xlink:type="extended" xlink:role="http://www.medicinova.com/role/InterimFinancialInformationDetails" xlink:title="0601 - Disclosure - Interim Financial Information (Details)" />
  <calculationLink xlink:type="extended" xlink:role="http://www.medicinova.com/role/IncomeTaxesDetails" xlink:title="0610 - Disclosure - Income Taxes (Details Textual)" />
  <calculationLink xlink:type="extended" xlink:role="http://www.medicinova.com/role/ShareBasedPaymentsDetailsTextual" xlink:title="06091 - Disclosure - Stock-Based Compensation (Details Textual)" />
  <calculationLink xlink:type="extended" xlink:role="http://www.medicinova.com/role/JointVenture" xlink:title="0203 - Disclosure - Joint Venture" />
  <calculationLink xlink:type="extended" xlink:role="http://www.medicinova.com/role/JointVentureDetails" xlink:title="0603 - Disclosure - Joint Venture (Details)" />
  <calculationLink xlink:type="extended" xlink:role="http://www.medicinova.com/role/FairValueMeasurementsTables" xlink:title="0504 - Disclosure - Fair Value Measurements (Tables)" />
  <calculationLink xlink:type="extended" xlink:role="http://www.medicinova.com/role/NetLossPerShareTables" xlink:title="0506 - Disclosure - Net Loss Per Share (Tables)" />
  <calculationLink xlink:type="extended" xlink:role="http://www.medicinova.com/role/NetLossPerShareDetailsTextual" xlink:title="06061 - Disclosure - Net Loss Per Share (Details Textual)" />
</linkbase>





